Published 2020 | Version v1
Publication

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia

Description

Coronavirus disease 2019 (COVID-19) can lead to respiratory failure due to severe immune response. Treatment targeting this immune response might be beneficial but there is limited evidence on its efficacy. The aim of this study was to determine if early treatment of patients with COVID-19 pneumonia with tocilizumab and/or steroids was associated with better outcome.

Additional details

Created:
April 14, 2023
Modified:
November 29, 2023